Baxter inaugurates global pharma R&D centre in Ahmedabad

Baxter Pharma today inaugurated the global pharma R&D centre in Ahmedabad. The centre will help further the company’s mission of saving and sustaining lives by accelerating innovation in the generic and differentiated injectable pharma space, a company statement notified.

It said that the R&D centre was inaugurated by Alok Sonig, President, Pharmaceuticals, Baxter International, in the presence of Dr Mahesh Chaubal, Vice President, Pharma R&D, Baxter International, and Sanju Dhawan, Director, R&D, Baxter Pharma.

The 20,500-square-foot, state-of-the-art centre features an array of sophisticated equipment and research labs that will focus on pharma product development and capabilities in therapeutic areas such as critical care, analgesic, renal, cardiovascular anesthesia, anti-infective and antipyretic. It will support Baxter’s global manufacturing facilities, including those in Ahmedabad, Germany, Ireland, Italy, and the US, among others, added the statement.

Dhawan said in the statement, “This R&D expansion broadens our presence in India while also acknowledging the country’s specialised capabilities and potential. We are delighted with the diverse pool of talent that the pharma R&D centre has, and we anticipate that it will attract even more talented professionals in the near future. This centre is indeed a significant step forward to achieve our mission to save and sustain lives by meeting the unmet needs of patients in India and throughout the world through innovation.”